Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Tornier Inc. readies $205 million IPO

June 8, 2010 11:39 am | by Mass Device | News | Comments

Minn.-based orthodpedic firm plans an estimated $205 million initial public offering By Thomas Lee Tornier Inc. is planning to test the choppy waters of Wall Street with an estimated $205 million initial public offering, according to documents filed with the Securities and...

TOPICS:

Psychological Intervention Provides Enduring Health Benefits for Women with Breast Cancer

June 8, 2010 11:38 am | by AACR | News | Comments

• Intervention improves survival rates following breast cancer recurrence. • Benefits were evident years after intervention ended. PHILADELPHIA - Stress-reducing psychological intervention helps to increase survival and quality of life among women with recurrent breast cancer over the...

TOPICS:

Counterfeit Polypropylene Surgical Mesh: Initial Communication

June 8, 2010 11:36 am | by U.S. Food & Drug Administration | News | Comments

[UPDATED 06/08/2010] Recall classified as Class I. Various sizes of counterfeit flat sheets of polypropylene surgical mesh marketed in the U.S. labeled with the C. R. Bard/Davol brand name.

TOPICS:
Advertisement

Class I Medical Device Recall: Counterfeit Polypropylene Surgical Mesh Products Marketed as C. R. Bard/Davol

June 8, 2010 10:38 am | by U.S. Food & Drug Administration | News | Comments

Various sizes of counterfeit flat sheets of polypropylene surgical mesh have been marketed in the United States labeled with the C. R. Bard/Davol brand name. These meshes, specifically identified below, are NOT Bard-manufactured products.

Poor health? Easier for some to blame bad genes than change lifestyle

June 8, 2010 9:38 am | by EurekAlert | News | Comments

(Springer) Does knowing that genes are partly responsible for your health condition mean you are less likely to be motivated to find out about the benefits of behavioral changes? Those with the greatest need to change their behaviors are more likely to favor genetic explanations...

TOPICS:

CTRC-AACR San Antonio Breast Cancer Symposium Abstract Submission Deadline June 21

June 8, 2010 9:37 am | by AACR | News | Comments

SAN ANTONIO - The deadline for submitting abstracts to the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium is June 21, 2010, at 11:59 p.m. CT. The symposium invites abstracts of proffered papers on the experimental biology, etiology, prevention, diagnosis and therapy of breast...

TOPICS:

New opto acoustic focusing technology stabilizes tiny biological samples

June 8, 2010 8:38 am | by I-Micronews | News | Comments

Purdue University researchers have developed a new method to fixate bacteria, viruses, and complex molecules like DNA inside liquid droplets by using both electric fields and laser light. The method may prove to be more effective and practical than separate light or sonic focusing units...

Total acquires interest in AE polysilicon, developer of a new polysilicon Production technology

June 8, 2010 8:38 am | by I-Micronews | News | Comments

Total announces that its subsidiary Total Gas & Power USA (SAS) has acquired a 25.4% interest in U.S. startup AE Polysilicon Corporation (AEP), which has developed an advanced technology to produce polysilicon for photovoltaic panels. The acquisition is being made through a reserved...

Advertisement

TSMC reveals plan for 3DIC designs based on Silicon interposers & TSV

June 8, 2010 8:38 am | by I-Micronews | News | Comments

According to a recent article from EETimes, Silicon foundry giant Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC) has expanded its ''platform'' initiative in an effort to speed up new designs in the foundry market. TSMC's initiative, dubbed the Open Innovation Platform (OIP), will now...

Cantel Medical fiscal 3Q profit edges higher

June 8, 2010 8:10 am | News | Comments

Cantel Medical Corp., which makes products used to prevent infections, said Tuesday its fiscal third-quarter net income rose 2.2 percent as sales grew in the company's largest divisions.Cantel said its profit grew to $4.3 million from $4.2 million. On a per-share basis, net income was unchanged...

RWJF and Pew award 6 grants to examine the impact of policy on people's health

June 8, 2010 7:42 am | by EurekAlert | News | Comments

(Burness Communications) The Health Impact Project, a collaboration of the Robert Wood Johnson Foundation and the Pew Charitable Trusts, today announced more than $1 million in grants to six projects that will conduct health impact assessments at the state and local levels.

TOPICS:

Biogen Idec and Elan initiate first-of-its-kind patient-reported outcomes research program in MS

June 8, 2010 7:41 am | by EurekAlert | News | Comments

(GCI Health) Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN), in collaboration with EPI-Q, Inc. and Avatar International, LLC, today announced the launch of My MS Health, a first-of-its-kind, web-based, patient-reported outcomes (PRO) research program. My MS Health...

TOPICS:

Tennessee judge rules no preemption in Stryker hip implant suit

June 8, 2010 5:41 am | by Mass Device | News | Comments

A federal judge in Tennessee rules that preemption does not apply in a product liability lawsuit over a Stryker Corp. hip implant. A federal judge in Tennessee ruled that preemption does not apply in the case of a product liability lawsuit over an allegedly defective Stryker...

TOPICS:

Public Meeting - Array-Based Cytogenetic Tests: Questions on Performance Evaluation, Result Reporting and Interpretation, June 30, 2010

June 8, 2010 5:36 am | by U.S. Food & Drug Administration | News | Comments

The purpose of this public meeting is to seek input on challenges related to performance evaluation, determination of clinical significance, result reporting, and interpretation for array-based cytogenetic tests.

TOPICS:

Federal Register: Array-Based Cytogenetic Tests: Questions on Performance Evaluation, Result Reporting and Interpretation; Public Meeting; Request for Comments

June 8, 2010 5:35 am | by U.S. Food & Drug Administration | News | Comments

The purpose of this public meeting is to seek input on challenges related to performance evaluation, determination of clinical significance, result reporting, and interpretation for array-based cytogenetic tests.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading